Showing 20,221 - 20,240 results of 104,898 for search '(( 2 de decrease ) OR ( 5 ((point decrease) OR (((nn decrease) OR (a decrease)))) ))', query time: 2.24s Refine Results
  1. 20221
  2. 20222
  3. 20223

    Pharmacology and Therapeutic Potential of Benzothiazole Analogues for Cocaine Use Disorder by Comfort A. Boateng (3617120)

    Published 2023
    “…Off-target antagonism of 5-HT<sub>2A</sub> or 5-HT<sub>2B</sub> may also contribute to these effects. …”
  4. 20224

    Table1_Effects of physical activity on the severity of illness and mortality in COVID-19 patients: A systematic review and meta-analysis.docx by Nuttawut Sittichai (14072646)

    Published 2022
    “…Subgroup analysis showed that PA for ≥150 min/wk at a moderate intensity or ≥75 min/wk at a vigorous intensity reduced the risks of severity and mortality. …”
  5. 20225

    Effects of maternal influenza vaccination on adverse birth outcomes: A systematic review and Bayesian meta-analysis by Sohyun Jeong (3712729)

    Published 2019
    “…Bayesian outcome probabilities (P) of an OR<1 were calculated, and values of at least 90% (0.9) were deemed to indicate a significant result.</p><p>Results</p><p>Among the 6,249 identified publications, 48 studies were eligible for the meta-analysis, including 2 randomized controlled trials, 41 cohort studies, and 5 case-control studies. …”
  6. 20226
  7. 20227
  8. 20228
  9. 20229

    Image_2_Distinct anti-NP, anti-RBD and anti-Spike antibody profiles discriminate death from survival in COVID-19.tif by Carolina do Prado Servian (17115112)

    Published 2023
    “…Introduction<p>Infection by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) induces rapid production of IgM, IgA, and IgG antibodies directed to multiple viral antigens that may have impact diverse clinical outcomes.…”
  10. 20230
  11. 20231

    Relative quantification comparisons of SP-A1 (A), SP-A2 (B), and SP-D (C) in ULTR treated with 5, 10 and 20 μg/ml of rhSPD after 6 and 12h (*p<0.05, **p<0.01, ***p<0.001). by Georgios Sotiriadis (834262)

    Published 2015
    “…<p>rhSP-D treatments resulted in an increase of SP-A1, SP-A2 and SP-D mRNA expression at 6 h at 5 and 10 μg/ml. …”
  12. 20232
  13. 20233
  14. 20234

    Indoxyl sulfate modulates FNDC5 expression in skeletal muscle cells. by Ming-Shien Wen (319221)

    Published 2013
    “…<p>A, Dose-response relationship for the decrease in FNDC5 expression in skeletal muscle cells treated with indoxyl sulfate for 24 h. …”
  15. 20235
  16. 20236

    A Comprehensive Study of Extended Tetrathiafulvalene Cruciform Molecules for Molecular Electronics: Synthesis and Electrical Transport Measurements by Christian R. Parker (1714033)

    Published 2014
    “…The molecules were subjected to a comprehensive study of their conducting properties as well as their photophysical and electrochemical properties in solution. …”
  17. 20237

    Image_4_CircFAM114A2 Promotes Cisplatin Sensitivity via miR-222-3p/P27 and miR-146a-5p/P21 Cascades in Urothelial Carcinoma.png by Jiancheng Lv (464636)

    Published 2021
    “…</p>Conclusion<p>CircFAM114A2 could inhibit progression and promote cisplatin sensitivity in urothelial carcinoma through novel circFAM114A2/miR-222-3p/P27 and circFAM114A2/miR-146a-5p/P21 pathways. …”
  18. 20238

    Image_6_CircFAM114A2 Promotes Cisplatin Sensitivity via miR-222-3p/P27 and miR-146a-5p/P21 Cascades in Urothelial Carcinoma.png by Jiancheng Lv (464636)

    Published 2021
    “…</p>Conclusion<p>CircFAM114A2 could inhibit progression and promote cisplatin sensitivity in urothelial carcinoma through novel circFAM114A2/miR-222-3p/P27 and circFAM114A2/miR-146a-5p/P21 pathways. …”
  19. 20239

    Image_7_CircFAM114A2 Promotes Cisplatin Sensitivity via miR-222-3p/P27 and miR-146a-5p/P21 Cascades in Urothelial Carcinoma.png by Jiancheng Lv (464636)

    Published 2021
    “…</p>Conclusion<p>CircFAM114A2 could inhibit progression and promote cisplatin sensitivity in urothelial carcinoma through novel circFAM114A2/miR-222-3p/P27 and circFAM114A2/miR-146a-5p/P21 pathways. …”
  20. 20240

    Image_3_CircFAM114A2 Promotes Cisplatin Sensitivity via miR-222-3p/P27 and miR-146a-5p/P21 Cascades in Urothelial Carcinoma.png by Jiancheng Lv (464636)

    Published 2021
    “…</p>Conclusion<p>CircFAM114A2 could inhibit progression and promote cisplatin sensitivity in urothelial carcinoma through novel circFAM114A2/miR-222-3p/P27 and circFAM114A2/miR-146a-5p/P21 pathways. …”